ViewPoint Therapeutics raised $4M Series A venture round, led by Mark Blumenkranz.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
| Venture Capital | — |
| University Fund | — |
| Venture Capital | — |
| Hedge Fund | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$39M
Top Valuation
-
ViewPoint Therapeutics raised $4M in a Series A round.
The round was announced on 05/06/16.
The round was led by Mark Blumenkranz, Douglas Crawford.